Molecular Imaging: Page 458

Fused MRI and PET improve specificity of breast MRI

By Wayne Forrest

Researchers at New York University's School of Medicine have found that the combination of functional information from F-18 FDG-PET and anatomic localization from MR imaging can provide a valuable diagnostic method for the detection of primary and recurrent breast cancer. The study noted that fused PET and MRI images substantially increased the specificity of MRI, but, at the same time, decreased MRI's sensitivity in the group of patients analyzed.

August 16, 2007

Molecular Insight appoints CFO

Molecular Insight Pharmaceuticals of Cambridge, MA has appointed a new chief financial officer.

August 15, 2007

Radiopharma recovery leads Covidien's imaging results

By AuntMinnie.com staff writers

Strong improvements in sales of its radiopharmaceutical products helped Covidien's imaging solutions business grow its sales by 5% in the third quarter of fiscal 2007 (end-June 30), the company's first quarterly reporting period since being spun off from Tyco International.

August 13, 2007

Breast gamma imaging spots DCIS better than mammo, MR

By Shalmali Pal

A dedicated breast gamma camera beat both mammography and MRI for the detection of ductal carcinoma in situ (DCIS), posting higher sensitivity ratings, according to a new study by Washington, DC, researchers. The study could add further fuel to the growing debate over the best modality to use when working up suspicious lesions detected on screening mammography.

August 12, 2007

Cardinal hires Philips executive

Healthcare products firm Cardinal Health of Dublin, OH, has named a former executive from Philips Medical Systems of Andover, MA, as executive vice president of strategy and corporate development.

August 12, 2007

Molecular Insight posts Q2 2007 results

By AuntMinnie.com staff writers

Cambridge, MA-based Molecular Insight Pharmaceuticals announced its second quarter 2007 (end-June 30) financial results.

August 12, 2007

Draxis Health posts second-quarter dip

By AuntMinnie.com staff writers

Canadian firm Draxis Health of Mississauga, Ontario, reported declines in consolidated revenues and earnings in the company's financial results for the second quarter and first six months of 2007 (end-June 30).

August 9, 2007

Orbotech to buy DDD

By AuntMinnie.com staff writers

Electronics industry technology firm Orbotech has signed a definitive agreement to purchase Danish cardiac gamma camera developer 3D Danish Diagnostic Development (DDD) for approximately $39 million.

August 6, 2007

Digirad posts Q2 profit

By AuntMinnie.com staff writers

Nuclear medicine firm Digirad posted its second straight quarter of profitability in its second quarter, thanks to higher margins.

August 6, 2007

PET becomes a godsend for newborns with hyperinsulinism

By Wayne Forrest

When a severe imbalance of insulin levels is confined to a limited section of a baby's pancreas, PET has shown to be extremely accurate in locating the abnormality at the Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania School of Medicine.

August 6, 2007

Is PET an endangered species?

By Dr. Richard Black

Just as it appeared ready to enter the clinical mainstream, PET imaging has been thrown a series of setbacks that raise questions as to whether it will ever live to up its potential. In this article, PET educator Dr. Richard Black discusses PET's spectacular rise, and also the threats that may bring it back to earth.

August 2, 2007

FDG-PET could help unlock secrets of atherosclerotic plaque

By Wayne Forrest

Two studies from Mount Sinai School of Medicine in New York City are shedding light on the role of FDG-PET in analyzing plaques in carotid arteries and the aorta as a precursor to cardiac health. Researchers said the studies are important because as much as 70% of all myocardial infarctions are due to the rupture of nonsclerotic lesions.

August 1, 2007

Previous Page

Page 458 of 615

Next Page